Pink Eye News and Research

RSS
Web-based system could help improve detection of disease outbreaks, say researchers

Web-based system could help improve detection of disease outbreaks, say researchers

RPS Diagnostics receives CE mark for FebriDx test

RPS Diagnostics receives CE mark for FebriDx test

NovaBay completes enrollment of patients in global Phase 2b viral conjunctivitis trial

NovaBay completes enrollment of patients in global Phase 2b viral conjunctivitis trial

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Tips to prevent bacterial pink eye

Tips to prevent bacterial pink eye

Study reveals that Hudson River polluted with antibiotic-resistant bacteria

Study reveals that Hudson River polluted with antibiotic-resistant bacteria

Researchers identify two promising candidates for development of drugs to combat adenovirus

Researchers identify two promising candidates for development of drugs to combat adenovirus

Viral conjunctivitis: potential new treatment

Viral conjunctivitis: potential new treatment

New mechanism may alter principle understandings of molecular interactions within a cell's nucleus

New mechanism may alter principle understandings of molecular interactions within a cell's nucleus

Guidelines for parents to beat back-to-school bugs

Guidelines for parents to beat back-to-school bugs

Acne pills can cause eye infections

Acne pills can cause eye infections

Mass. Eye and Ear cornea specialist wins RPB Senior Scientific Investigator Award

Mass. Eye and Ear cornea specialist wins RPB Senior Scientific Investigator Award

First study to describe transporter system that bacteria use to ensure their survival

First study to describe transporter system that bacteria use to ensure their survival

Scientists report discovery of potential new drug for epidemic keratoconjunctivitis

Scientists report discovery of potential new drug for epidemic keratoconjunctivitis

NovaBay third quarter net loss increases to $1.6 million

NovaBay third quarter net loss increases to $1.6 million

NovaBay delivers two poster presentations on Aganocide compounds at IDSA Annual Meeting

NovaBay delivers two poster presentations on Aganocide compounds at IDSA Annual Meeting

NovaBay to present two poster presentations at IDSA Annual Meeting

NovaBay to present two poster presentations at IDSA Annual Meeting

NovaBay Pharmaceuticals delivers poster presentations on Aganocide compound at ICAAC Conference

NovaBay Pharmaceuticals delivers poster presentations on Aganocide compound at ICAAC Conference

NovaBay Pharmaceuticals to deliver new data on Aganocide compounds at ICAAC Conference

NovaBay Pharmaceuticals to deliver new data on Aganocide compounds at ICAAC Conference

NovaBay Pharmaceuticals issued Notice of Allowance for broad portfolio of anti-infective compounds

NovaBay Pharmaceuticals issued Notice of Allowance for broad portfolio of anti-infective compounds